BITOSSI, ALICE
 Distribuzione geografica
Continente #
NA - Nord America 623
EU - Europa 553
AS - Asia 154
AF - Africa 3
OC - Oceania 2
SA - Sud America 1
Totale 1.336
Nazione #
US - Stati Uniti d'America 617
RU - Federazione Russa 241
IT - Italia 98
PL - Polonia 77
IE - Irlanda 43
HK - Hong Kong 35
SE - Svezia 35
SG - Singapore 32
CN - Cina 26
IN - India 25
CH - Svizzera 24
JO - Giordania 21
FI - Finlandia 16
DE - Germania 8
CA - Canada 6
VN - Vietnam 6
GB - Regno Unito 5
ID - Indonesia 4
AU - Australia 2
BE - Belgio 2
CI - Costa d'Avorio 2
ES - Italia 2
KR - Corea 2
AT - Austria 1
BR - Brasile 1
JP - Giappone 1
KZ - Kazakistan 1
MA - Marocco 1
NL - Olanda 1
TR - Turchia 1
Totale 1.336
Città #
Santa Clara 228
Warsaw 77
Fairfield 50
Dublin 43
Chandler 40
Singapore 28
Woodbridge 28
Ashburn 25
Bern 24
Hong Kong 24
Florence 22
Altamura 20
Lawrence 20
Moscow 19
Cambridge 16
Helsinki 14
Houston 13
Shanghai 12
Princeton 11
Seattle 11
Mumbai 10
Boston 9
Wilmington 9
Boardman 8
New York 8
Buffalo 7
Dong Ket 6
Ann Arbor 5
Bengaluru 5
Hillsboro 5
Bologna 4
Cagliari 4
Castelfranco di Sotto 4
Jakarta 4
Medford 4
Altidona 3
Chennai 3
Falls Church 3
Islington 3
Kent 3
Norwalk 3
San Diego 3
Somerville 3
Strada in Chianti 3
Taizhou 3
Toronto 3
Vaddangi 3
Washington 3
Yubileyny 3
Abidjan 2
Agliana 2
Bari 2
Brussels 2
Desio 2
Gurugram 2
Lappeenranta 2
Leawood 2
Los Angeles 2
Melbourne 2
Montréal 2
Osio Sotto 2
Pesaro 2
Rome 2
Sorbolo 2
Stezzano 2
West Jordan 2
Almaty 1
Andover 1
Araripe 1
Beijing 1
Castelliri 1
Irkutsk 1
Jacksonville 1
Kochi 1
Melilla 1
Munich 1
New Delhi 1
Norwich 1
Padova 1
Rabat 1
Redwood City 1
Reggio Emilia 1
Secaucus 1
Seoul 1
Stoney Creek 1
Telgate 1
Terranuova Bracciolini 1
Valladolid 1
Vienna 1
Wernigerode 1
Wuhan 1
Totale 918
Nome #
Adalimumab Accounts for Long-Term Control of Noninfectious Uveitis Also in the Absence of Concomitant DMARD Treatment: A Multicenter Retrospective Study 170
Adalimumab effectively controls both anterior and posterior noninfectious uveitis associated with systemic inflammatory diseases: focus on Behçet’s syndrome 153
Morpho-Functional Evaluation of Full-Thickness Macular Holes by the Integration of Optical Coherence Tomography Angiography and Microperimetry 125
I farmaci biologici 106
Long-term Retention Rates of Adalimumab and Infliximab in Non-Infectious Intermediate, Posterior, and Panuveitis 101
Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients 99
Efficacy of adalimumab and infliximab in recalcitrant retinal vasculitis inadequately responsive to other immunomodulatory therapies 99
Evaluation of intraoperative slow-release dexamethasone implant combined with idiopathic epiretinal membrane removal 88
Non-anti TNFα biologic agents for noninfectious uveitis associated with systemic inflammatory diseases: a systematic review 86
Efficacy of adalimumab for the treatment of noninfectious uveitis in a real world setting 84
Efficacy of anti-tumour necrosis factor-α monoclonal antibodies in patients with non-infectious anterior uveitis 84
Epidemiology of Psoriasis and Psoriatic Arthritis in Italy—a Systematic Review 81
Efficacy of monoclonal anti-tumour necrosis factor-α antibodies in uveitic macular oedema 79
Totale 1.355
Categoria #
all - tutte 4.374
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.374


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202045 0 0 0 0 0 0 0 7 7 6 9 16
2020/2021166 9 15 2 14 36 13 25 7 15 13 3 14
2021/202266 0 1 4 2 0 13 0 4 3 4 10 25
2022/2023265 19 63 15 4 7 34 25 14 41 5 12 26
2023/2024173 4 10 17 10 13 21 4 33 18 19 7 17
2024/2025612 31 78 49 141 200 95 13 5 0 0 0 0
Totale 1.355